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Staphylococcal scalded skin syndrome and its loca-
lized form, bullous impetigo, show super®cial epi-
dermal blister formation caused by exfoliative toxin
A or B produced by Staphylococcus aureus. Recently
we have demonstrated that exfoliative toxin A specif-
ically cleaves desmoglein 1, a desmosomal adhesion
molecule, that when inactivated results in blisters. In
this study we determine the target molecule for exfo-
liative toxin B. Exfoliative toxin B injected in neo-
natal mice caused super®cial epidermal blisters,
abolished cell surface staining of desmoglein 1, and
degraded desmoglein 1 without affecting desmoglein
3 or E-cadherin. When adenovirus-transduced
cultured keratinocytes expressing exogenous mouse
desmoglein 1 or desmoglein 3 were incubated with
exfoliative toxin B, desmoglein 1, but not desmo-
glein 3, was cleaved. Furthermore, cell surface stain-
ing of desmoglein 1, but not that of desmoglein 3,
was abolished when cryosections of normal human
skin were incubated with exfoliative toxin B, sug-
gesting that living cells were not necessary for exfo-
liative toxin B cleavage of desmoglein 1. Finally,
in vitro incubation of the recombinant extracellular
domains of desmoglein 1 and desmoglein 3 with
exfoliative toxin B demonstrated that both mouse
and human desmoglein 1, but not desmoglein 3,
were directly cleaved by exfoliative toxin B in a
dose-dependent fashion. These ®ndings demonstrate
that exfoliative toxin A and exfoliative toxin B cause
blister formation in staphylococcal scalded skin syn-
drome and bullous impetigo by identical molecular
pathophysiologic mechanisms. Key words: cadherin/
impetigo/pemphigus foliaceus/skin infection/SSSS. J Invest
Dermatol 118:845±850, 2002
S
taphylococcal scalded skin syndrome (SSSS) is a general-
ized blistering skin disease induced by the exfoliative
(epidermolytic) toxin (ET) of Staphylococcus aureus (Melish
and Glasgow, 1970; Melish et al, 1972). It was also known
in the past as Ritter's disease, dermatitis exfoliativa
neonatorum, or pemphigus neonatorum. It is a disease primarily
affecting infants and young children, but adults can also be affected.
Its clinical manifestations begin abruptly with fever, skin tenderness,
and erythema, followed by large sheets of epidermal separation
involving the entire skin surface within hours to days. The
mortality is still 3% in children (Gemell, 1995), and over 50% in
adults with underlying diseases despite antibiotic treatment (Cribier
et al, 1984). SSSS caused by antibiotic-resistant strains of S. aureus
has recently emerged as an even more serious problem (Yokota et
al, 1996; Acland et al, 1998). The pathogenic role of ET in SSSS is
well established. For example, ET injected into neonatal mice
causes extensive blisters similar to the disease manifestations in
human neonates (Melish and Glasgow, 1970). In SSSS, S. aureus is
present at distant foci such as the pharynx, nose, ear, or conjunctiva,
and ET produced by S. aureus gets into circulation and causes
exfoliation at remote sites, whereas in bullous impetigo, a localized
form of SSSS, S. aureus is present in the lesions.
ET has two major serotypes A and B (ETA and ETB). In the
U.S.A. and Europe more than 80% of toxin-producing S. aureus
produce ETA (Cribier et al, 1984), whereas in Japan there is a
predominance of ETB-producing strains (Murono et al, 1988). The
gene encoding ETA is located on the chromosome whereas the
gene encoding ETB is found on a large plasmid. The genes for
ETA and ETB have been cloned and their amino acid sequences
have been deduced (O'Toole and Foster, 1986; Lee et al, 1987).
The mature proteins of ETA and ETB are 242 and 246 residues,
respectively, after their signal sequences are cleaved. The ETA and
ETB amino acid sequences are about 40% identical to each other.
Although previous ultrastructural studies have shown intercel-
lular cleavage with split desmosomes after injection of ET into
neonatal mice, it was not clear whether disruption of desmosomes
is an initial event or a secondary event that occurs only after edema
caused by other intercellular pathology (Lillibridge et al, 1972;
Melish et al, 1974; Elias et al, 1975; Dimond et al, 1977). ETs have
also been reported to be superantigens (Choi et al, 1989; Kappler et
al, 1989), which bind to major histocompatibility complex class II
molecules on antigen-presenting cells and to the variable parts of
the T cell receptor, resulting in polyclonal T cell activation. Other
investigators have argued, however, that the previous demonstra-
tion of superantigenic activity with ETs was probably due to
contamination with other staphylococcal enterotoxins (Fleischer
and Bailey, 1992; Fleischer et al, 1995). Therefore, until recently,
the molecular mechanism of the epidermal separation by ET had
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been unclear, even 30 y after the pathogenic role of ET was
demonstrated using neonatal mice in 1970 (Ladhani et al, 1999).
The clue to how ETA might cause the blister was provided by
studies of the pathophysiology of pemphigus foliaceus, an
autoimmune blistering disease, in which inactivation of the
desmosomal cadherin desmoglein 1 (Dsg1) by autoantibodies was
shown to cause clinical and histologic blisters similar to those seen
in bullous impetigo and SSSS (Stanley, 1993; Amagai, 1999;
Mahoney et al, 1999). These observations led us to hypothesize and
prove that ETA speci®cally cleaves Dsg1 (Amagai et al, 2000).
In this study, we determine that the molecular pathophysiology
of blistering caused by ETB is identical to that of ETA, namely the
direct cleavage of Dsg1.
MATERIALS AND METHODS
Construction of recombinant ETB ETB-producing S. aureus TY4
chromosomal DNA was prepared as described previously (Sugai et al,
1998; Yamaguchi et al, 2001) and used as a polymerase chain reaction
(PCR) template. A primer set, 5¢-AAGCTTCCACCTAATACCCT-
AATAATC-3¢ and 5¢-GGATCCACAGAGGTTCAACTCATGGTT-3¢,
was designed to generate a 1148 bp DNA fragment containing the entire
etb gene (M17348) (Jackson and Iandolo, 1986) with terminal HindIII
and BamHI sites. The PCR product was cloned into pGEM-T Easy
vector to generate pTY231. The pTY231 was digested with HindIII and
BamHI, and the insert was cloned into E. coli±S. aureus shuttle vector
pCL8 to generate pTY133. S. aureus RN4220 (NCTC8325-4r-), which
is a standard strain with no production of ETA or ETB, was then
transformed with pTY133, and one of the transformants was designated
TY2134. The physical map and genetic determinants of NCTC8325
indicate that this strain does not possess eta or etb (Iandolo, 2000). The
nucleotide sequence of the etb gene was con®rmed by DNA sequencing.
Staphylococcus aureus TY2134 exponentially growing in Trypticase soy
broth (Becton Dickinson Microbiology Systems, Cockeysville, MD) was
inoculated in 1 liter of the same fresh medium and incubated with
continuous agitation by a rotary shaker for 24 h at 37°C until the cells
reached the stationary phase. The culture was centrifuged at 10,000 3 g
for 20 min at 4°C. Concentrated culture ®ltrate was prepared by 80%
saturated ammonium sulfate precipitation of the culture supernatant. A
sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE)
and subsequent Coomassie Brilliant Blue staining of concentrated culture
®ltrate revealed a single major protein band of 27 kDa, which was not
present in the concentrated culture ®ltrate of RN4220 pCL8. We
therefore used Coomassie Brilliant Blue staining of SDS-PAGE gel for
detection of the ETB-positive fraction with the 27 kDa band as the
marker. Concentrated culture ®ltrate dialyzed against 10 mM phosphate
buffer (pH 6.8) (buffer 1) was applied to a hydroxyapatite column
(Wako, 15 mm 3 90 mm), which was equilibrated with buffer 1. The
column was washed with buffer 1 until most of the unbound proteins
passed through. Bound proteins were eluted by stepwise elution with
100 mM, 250 mM, and 500 mM phosphate buffer (pH 6.8), respect-
ively. Eluate with 100 mM phosphate buffer (pH 6.8) was dialyzed
against 10 mM phosphate buffer (pH 6.8) (buffer 2) and concentrated to
500 ml. The sample was loaded onto TSKgel SW3000XL (Tosoh,
7.5 mm 3 300 mm) and eluted with buffer 2 at a ¯ow rate of 0.5 ml
per min, and the ETB-positive fractions were collected. Those fractions
were collected and further applied to Bioscale CHT2-I hydroxyapatite
HPLC column (Bio-Rad, 7.5 mm 3 52 mm), and eluted with a linear
gradient from 10 mM to 500 mM phosphate buffer (pH 6.8) at a ¯ow
rate of 1 ml per min. The ETB-positive fractions were collected and
extensively dialyzed against phosphate-buffered saline (PBS). This puri-
®ed ETB was used for incubation with cryosections of normal human
skin (see below) and recombinant Dsg1 and Dsg3 (see below).
We also cloned the etb gene by a similar approach using an ETB-
producing S. aureus isolated from a patient as a PCR template. A primer
set, 5¢-ACCCTAATAATCCAAAAACAG-3¢ and 5¢-CACAGAGGTT-
CAACTCATGGT-3¢, was used to amplify the etb gene and promoter
sequence, and the PCR products were ligated into the pCRII vector
and then subcloned into the pCE104 vector (a kind gift from Dr. Patrick
Schlievert) (Vath et al, 1997). The supernatant from S. aureus RN4220
transformed with this plasmid contained ETB as the major protein,
which was greater than 90% pure as determined by SDS-PAGE. This
partially puri®ed ETB was used for incubation with transduced HaCaT
cells (see below) and injected into neonatal mice prior to immuno-
¯uorescence and immunoblotting of epidermis (see below).
Neonatal mouse study with ETB To evaluate the exfoliative activity
of recombinant ETB, neonatal ICR or BALB/C mice (< 24 h of age)
were injected subcutaneously with a designated amount of ETB in 20±
50 ml of PBS, and the skin was analyzed grossly and microscopically 1±
24 h after injection.
Mouse back skin was homogenized on dry ice, and then extracted
with Laemmli sample buffer. Samples with equal amounts of protein
(protein assay kit; Bio-Rad Laboratories, Hercules, CA) were separated
by 6% Tris±glycine PAGE (Novex gels; Invitrogen, Carlsbad, CA), and
then transferred to nitrocellulose membranes (Trans-Blot; Bio-Rad
Laboratories). The membranes were incubated with rabbit antiserum
against mouse Dsg1 and Dsg3, and ECCD-2 rat monoclonal antibody
against mouse E-cadherin (a kind gift from M. Takeichi) (Shirayoshi et
al, 1986).
Cell culture study with ETB To transduce cells with constructs
encoding mouse Dsg1 and mouse Dsg3 with FLAG tag, recombinant
adenovirus was constructed. The cosmid cassette pAxCAw, control Ad
Ax1w, and the parent virus Ad5-dLX were all kind gifts from Dr. Izumi
Saito (Tokyo University, Japan) (Miyake et al, 1996). cDNA encoding
mouse Dsg1-FLAG and mouse Dsg3-FLAG (Amagai et al, 2000) were
subcloned into the Ad cosmid cassette pAxCAw. Adenovirus containing
CA promoter and cDNA encoding mouse Dsg1-FLAG and mouse
Dsg3-FLAG (AxmDsg1F and AxmDsg3F) were generated by the COS-
TPC method (Miyake et al, 1996) as follows. The cosmid DNA was
mixed with the EcoT22I-digested DNA-terminal protein complex of
Ad5-dLX and used to cotransfect to 293 cells in which recombinant
viruses were generated through homologous recombination. Virus stocks
were prepared using standard procedures (Miyake et al, 1996), and were
concentrated by the CsCl gradient method. The virus titer was checked
with a plaque formation assay.
HaCaT cells were cultured in a 12-well plate and transduced with
AxmDsg1F and AxmDsg3F. After 24 h the cells were incubated with 0,
0.05, 0.15, and 0.25 mg per ml of recombinant ETB in culture media
and incubated for 10 min or 1 h. Then the cells were washed with PBS,
and extracted with 200 ml 2 3 SDS Laemmli sample buffer (Bio-Rad
Laboratories). The transduced Dsg1 and Dsg3 were visualized by
immunoblotting with anti-FLAG tag rabbit antibody (Zymed, San
Francisco, CA).
Immuno¯uorescence Formalin-®xed, paraf®n-embedded skin from
neonatal mice injected with ETB or saline was used for indirect
immuno¯uorescence to localize Dsg1, Dsg3, and E-cadherin, as
previously described (Amagai et al, 2000). A rabbit antiserum against
extracellular domain 5 of mouse Dsg3 was raised and af®nity puri®ed on
the antigenic peptide. A rabbit antiserum, raised similarly against
extracellular domain 5 of mouse Dsg1, and ECCD-2 were also used.
Stained sections were photographed using confocal microscopy (Leica
TCS 4D, Wetzlar, Germany).
Cryosections of non®xed normal human skin were incubated with
0.1 mg per ml of ETA (Toxin Technology, Sarasota, FL) in PBS with
1 mM CaCl2 (PBS-Ca), 0.1 mg per ml of recombinant ETB in PBS-Ca,
or PBS-Ca alone for 1 h at room temperature. The sections were then
stained with anti-Dsg1 sera obtained from patients with pemphigus
foliaceus, anti-Dsg3 mouse monoclonal antibody, 5H10, which reacts
with the extracellular domain (Proby et al, 2000), anti-Dsg1 + 2 mouse
monoclonal antibody, DG3.10, which reacts with the cytoplasmic
domain (Koch et al, 1990), antidesmocollin mouse monoclonal antibody,
52-3D, which reacts with the cytoplasmic domain of Dsc1±3 (a kind gift
from Dr. D. R. Garrod) (Collins et al, 1991), and antidesmoplakin
mouse monoclonal antibody, 11-5F (a kind gift from Dr. D. R. Garrod).
Staining with DG3.10 in this study represents the expression of Dsg1
because there is no detectable expression of Dsg2 in normal human skin.
In vitro digestion of recombinant Dsg1 with ETB The entire
extracellular domain of mouse and human recombinant Dsg1 and Dsg3,
with an E-tag on the carboxyl terminus, were produced as a secreted
protein by baculovirus expression as previously described (Ishii et al,
1997; Amagai et al, 2000). These recombinant human Dsg1 and Dsg3
proteins have been shown to retain their native conformations enough to
adsorb out all immunoreactivity of pemphigus foliaceus and vulgaris sera,
respectively (Ishii et al, 1997). High Five cells (Invitrogen, San Diego,
CA) cultured in serum-free EX Cell 405 medium (JRH Bioscience,
Lenexa, KS) were infected with the recombinant viruses and incubated
for 3 d. Culture supernatant containing each recombinant Dsg was
incubated with the indicated amount of ETB for 1 h at 37°C, and
subsequently subjected to immunoblot analysis with anti-E-tag mouse
monoclonal antibody (Pharmacia Biotech, Uppsala, Sweden) for
detection of the intact as well as digested recombinant proteins. Culture
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supernatant of RN4220 transfected with etb, but not that of RN4220
itself, digested recombinant Dsg1, indicating that RN4220 did not
produce any ET (data not shown).
RESULTS
Production of recombinant ETB cDNA for ETB was PCR-
ampli®ed from ETB-producing S. aureus TY4, subcloned into an
E. coli±S. aureus shuttle vector (pTY133), and used to transform S.
aureus RN4220 (TY2134). TY2134 produced ETB in culture
supernatant, which was recognized as a single predominant band of
27 kDa by Coomassie Blue. N-terminal sequencing of the protein
band identi®ed that it was the correctly processed form of
recombinant ETB (data not shown). Finally 360 mg recombinant
ETB was puri®ed to homogeneity from 1 liter of culture
supernatant as described in Materials and Methods (Fig 1A).
To con®rm the exfoliative activity of the recombinant ETB, 20
mg of ETB in 100 ml of PBS was subcutaneously injected into
neonatal mice. The mice started to show gross blisters as soon as 2±
3 h after injection around the injected site (Fig 1B; compare to
control Fig 1C).
Dsg1, but not Dsg3 or E-cadherin, was degraded in vivo in
neonatal mouse skin injected with ETB To investigate the
molecular mechanism of the blister formation by ETB and to
determine whether ETB speci®cally affects Dsg1 as does ETA
(Amagai et al, 2000), we examined the skin from neonatal mice
injected with ETB by immuno¯uorescence with antibodies to
Dsg1, Dsg3, and E-cadherin. When the skin was examined 1 h after
ETB injection, the cell surface staining of Dsg1 was markedly
diminished (Fig 2B; compare to control Fig 2A). In the same area,
the cell surface staining of Dsg3 or E-cadherin was unaffected
(Fig 2C±F).
To determine whether this change in Dsg1 staining was caused
by degradation of Dsg1 in the neonatal mouse skin, extracts of the
skin from the mice injected with ETB or PBS were subjected to
immunoblot analysis for Dsg1, Dsg3, and E-cadherin. A 160 kDa
band for Dsg1 was degraded into a band of approximately 113 kDa
in all three mice injected with ETB, whereas Dsg3 and E-cadherin
were not degraded (Fig 3).
These results indicate that Dsg1, but not Dsg3 or E-cadherin,
was cleaved in vivo in neonatal mouse skin after injection with ETB.
Exogenous Dsg1, but not Dsg3, was degraded by addition of
ETB to transduced HaCaT cells To further demonstrate
speci®c cleavage of Dsg1 by ETB, we transduced HaCaT cells, a
human keratinocyte cell line, with recombinant adenovirus
containing cDNA encoding mouse Dsg1 or Dsg3 with a FLAG
epitope tag on their C-termini. When 50 mg per ml of ETB was
Figure 1. Production of recombinant ETB with exfoliative
activity. Coomassie Blue stained SDS-PAGE shows recombinant ETB
was produced as a 27 kDa peptide (A). Neonatal mice injected with
ETB showed extensive blisters 2 h after injection (B), whereas neonatal
mice injected with saline alone did not blister (C ).
Figure 2. Immuno¯uorescence staining of cadherins in the
epidermis of mice injected with ETB. Neonatal mice were injected
with PBS (A, C, E) or ETB (B, D, F) and stained for Dsg1 (A, B), Dsg3
(C, D), and E-cadherin (E, F). Dsg1 staining showed that the cell surface
staining of Dsg1 was removed by injection of ETB. The stainings of
Dsg3 and E-cadherin were not affected by injection of ETB. Arrowheads
indicate the location of the basement membrane zone. Scale bar: 50 mm
Figure 3. Immunoblot analysis of skin extracts from neonatal
mice injected with PBS or ETB. Dsg1 was degraded by ETB
injection, whereas Dsg3 and E-cadherin were not affected. Each lane
represents an extract from a different mouse. Arrowheads and arrows
indicate intact Dsg1 and cleaved Dsg1, respectively.
Figure 4. Immunoblot analysis of extracts from cultured
keratinocytes incubated with ETB. (A) HaCaT cells were transduced
with recombinant adenovirus with mouse Dsg1 (Dsg1) or mouse Dsg3
(Dsg3) or control adenovirus without any insert (C), and incubated with
50 mg per ml ETB for 1 h. Exogenous Dsg1 and Dsg3 was visualized
anti-FLAG tag antibody. Dsg1, but not Dsg3, was degraded by ETB.
Arrowheads, asterisk, and arrows indicate intact Dsg1, intact Dsg3, and
cleaved Dgs1. (B) HaCaT cells transduced with recombinant adenovirus
with Dsg1 was incubated with various amounts of ETB for 10 min or
1 h. Dsg1 was degraded by ETB in a dose- and time-dependent fashion.
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added to the culture medium of these cells and incubated for 1 h,
Dsg1 was degraded whereas Dsg3 was not (Fig 4A). When these
transduced HaCaT cells were incubated with various amounts of
ETB (0, 0.05, 0.15, and 0.25 mg per ml) for 10 min or 1 h, Dsg1
was cleaved in a dose- and time-dependent fashion to a 113 kDa
product (Fig 4B).
Dsg1 cleavage by ETB is a direct effect The in vivo ®ndings
described above do not prove that ETB directly degrades Dsg1, as
opposed to, for example, degradation through activation of other
proteases in living cells. Therefore, to ®rst demonstrate that living
cells are not necessary for this inactivation of Dsg1, we incubated
cryosections of normal human skin with ETB, ETA, or PBS, as a
control, and stained them with antibodies against various
desmosomal components (Fig 5). The cell surface staining of
Dsg1 by pemphigus foliaceus sera, which react with the
extracellular domain of Dsg1 (Amagai et al, 1995), was removed
by ETB, whereas that of Dsg3 by 5H10, which reacts with the
amino terminal extracellular domain of Dsg3 (Proby et al, 2000),
was not altered at all (Fig 5A, C, D, F). These effects by ETB on
the Dsg1 and Dsg3 staining were identical to those by ETA
(Fig 5B, E). ETB treatment did not affect the staining pattern by
monoclonal antibody DG3.10, which recognizes the cytoplasmic
domain of Dsg1 (Fig 5G). ETB treatment did not alter the staining
of desmocollin by 52-3D nor that of desmoplakin by 11-5F
(Fig 5H, I). ETA treatment did not change the staining by
DG3.10, 52-3D, or 11-5F, either (data not shown). These ®ndings
indicate that ETB as well as ETA speci®cally affect the extracellular
domain of Dsg1 in the absence of living cells, presumably by
cleavage.
Figure 5. In vitro ETB treatment of cryosectioned normal human skin. Non-®xed cryosectioned normal human skin was incubated with ETA
(B, E), ETB (C, F, G, H, I)or PBS alone (A, D), and stained for extracellular domain of Dsg1 (A, B, C), extracellular domain of Dsg3 (D, E, F),
cytoplasmic domain of Dsg1 (G), cytoplasmic domain of desmocollin (Dsc, H)or desmoplakin (DP, I). The staining for the extracellular domain of
Dsg1 was removed by ETB (C)as seen with ETA (B), whereas the staining for Dsg3 was not affected. The staining for the cytoplasmic domain of
Dsg1, desmocollins, or desmoplakin was not affected. Scale bar: 50 mm
Figure 6. In vitro ETB treatment of recombinant extracellular domain of Dsg1 and Dsg3. Mouse (A) or human (B) Dsg1 and Dsg3
extracellular domains produced in baculovirus were incubated with various amounts of ETB (A: lane 1, 10 mg per ml; lane 2, 3 mg per ml; lane 3, 1 mg
per ml; lane 4, 0.3 mg per ml; lane 5, 0.1 mg per ml; lane 6, 0 mg per ml; B: lane 1, 1 mg per ml; lane 2, 0.3 mg per ml; lane 3, 0.1 mg per ml; lane 4,
0.03 mg per ml; lane 5, 0.01 mg per ml; lane 6, 0 mg per ml), and subjected to immunoblots and visualized with anti-E-tag monoclonal antibody. The
extracellular domain of Dsg1, but not that of Dsg3, was cleaved by ETB in a dose-dependent fashion. Arrowheads and arrows indicate the intact
recombinant Dsg1 and cleaved product, respectively. Bars on the left side indicate molecular weight standards 250, 100, 50, and 25 kDa, from top to
bottom.
848 AMAGAI ET AL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
To demonstrate direct proteolysis of the extracellular domain of
Dsg1 by ETB, we incubated a soluble recombinant form of the
extracellular domain of Dsg1 and Dsg3 with ETB in vitro (Fig 6).
ETB cleaved the 81 kDa recombinant mouse Dsg1 down to a 34
kDa peptide in a dose-dependent fashion, whereas ETB did not
cleave mouse Dsg3 at all. In the same way, ETB cleaved the
recombinant human Dsg1, but not human Dsg3. These ®ndings
indicate that ETB speci®cally recognizes and cleaves the extra-
cellular domain of both mouse and human Dsg1.
DISCUSSION
The major physiologic function of skin is to form a protective
barrier that hampers the penetration of microorganisms and inhibits
the loss of water. This barrier has been shown to reside in the
stratum corneum. In bullous impetigo, S. aureus is found in a blister
cavity just beneath the stratum corneum, thus circumventing the
barrier. This blister cavity is known to be caused by ET, released by
the pathologic organisms. A similar blister occurs in patients with
the autoimmune disease pemphigus foliaceus. In that disease IgG
autoantibodies against Dsg1 block the cell adhesion function of
Dsg1 with resultant super®cial blisters in the epidermis where Dsg1
is expressed without coexpressed Dsg3 (Amagai, 1999; Mahoney et
al, 1999). Although Dsg1 is also expressed in the deep epidermis
and mucous membranes, blisters do not occur in these areas because
Dsg3 is coexpressed and can compensate for the antibody-induced
loss of function of Dsg1. Because pemphigus foliaceus shows
identical tissue speci®city and histology to SSSS and bullous
impetigo, which are caused by ET, we previously suspected that
the target molecule for a major type of ET, ETA, might be Dsg1
and proved that ETA speci®cally cleaves Dsg1 (Amagai et al, 2000).
In this study, we hypothesized that another type of ET that
causes SSSS and bullous impetigo, ETB, also cleaves Dsg1. We
have shown that injection of recombinant ETB into neonatal mice
caused the speci®c removal of cell surface staining of Dsg1 and the
degradation of Dsg1 in vivo with resultant blister formation, whereas
Dsg3 and E-cadherin were not affected. Similarly, when ETB was
added to cultured keratinocytes expressing tagged Dsg1 or Dsg3,
ETB digested Dsg1 without affecting Dsg3. Speci®c loss of
immuno¯uorescence of Dsg1, but not other cell surface molecules,
after incubation of normal human skin with ETB, suggested that
inactivation of Dsg1 by ETB did not require living cells and was
probably a direct effect. Finally, we have demonstrated that ETB
speci®cally cleaved the recombinant extracellular domain of Dsg1,
but not that of Dsg3, in vitro. These ®ndings indicate that ETB
recognizes the extracellular domain of Dsg1 and cleaves it directly.
Histologic studies suggested that ET binds to a receptor in the
granular layer of the epidermis, although to keratohyalin granules,
not to the cell surface (Smith et al, 1989). Other studies have
suggested binding to an epidermal GM4-like glycolipid (Sakurai
and Kondo, 1979; Tanabe et al, 1995). Our studies demonstrate
direct cleavage of recombinant Dsg1 in solution, however,
suggesting that any epidermal receptor other than Dsg1 is
unnecessary for activation of ET's proteolytic activity.
It is hypothesized that ETA and ETB are serine proteases. ETA
and ETB are 25% identical to the staphylococcal serine protease
V8. Structural studies show particularly striking homology in the
region of the serine±aspartic acid±histidine catalytic triad that forms
the active site of trypsin-like serine proteases (Dancer et al, 1990).
In addition, the X-ray crystal structure of ETA and ETB showed
signi®cant structure similarity with known glutamate-speci®c
trypsin-like serine proteases (Vath et al, 1997; 1999). It is interesting
that ETA and ETB share identical binding speci®city and cleavage
speci®city although overall identity is only 40%. We suspect that
amino acid residues that are responsible for this speci®city should be
conserved. The ®nal identi®cation of ETA and ETB as glutamate-
speci®c serine proteases has to await the determination of the
cleavage site of Dsg1 by ETA and ETB.
Dsg1 is targeted by ETA as well as ETB in SSSS and bullous
impetigo, resulting in a blister just below the stratum corneum, the
major barrier in skin. These toxins, then, allow the bacteria to
circumvent this barrier and spread just beneath it. These ®ndings
provide an important framework to understand the molecular
mechanism for blister formation in these diseases as well as cell±cell
adhesion of keratinocytes in the epidermis.
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